1. Background {#sec1}
=============

Diabetes mellitus (DM) is a non-communicable disease and one of the most common chronic diseases \[[@bib1]\]. World health organization defined DM as a metabolic disorder of multiple etiology characterized by chronic hyperglycemia with disturbances of carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, insulin action, or both \[[@bib2]\]. Complications of DM become a major public health problem in all countries \[[@bib3]\]. It is characterized by multiple long-term complications affecting almost every system in the body and often leads to blindness, heart and blood vessel disease, stroke, kidney failure, amputations, and nerve damage \[[@bib4]\].

Diabetic patients who present with foot ulceration are associated with many risk factors. Peripheral arterial disease (PAD) is present in approximately one-half of all patients with foot ulcers and considered an important predictor of outcome \[[@bib5]\]. Patients in whom their foot ulcer progressed to diabetic foot infections not only suffer from prolonged hospitalization but also leads to amputations of their foot which increases the rates of mortality \[[@bib6]\]. Along with increased morbidity, foot ulcers can lead to lifelong disability and substantially diminish the quality of life (QOL) for these patients. Specifically, patients with diabetic foot ulcer (DFU) have restrictions on mobility, poor psychosocial adjustment, and lower self-perceptions of health than patients who do not have ulcers. The survival rate of patients with diabetic foot ulcer was decreased compared to diabetes patients without foot ulcer \[[@bib7],[@bib8]\].

DM has been established as one of the most common and important disease states associated increased risk of postoperative infections and poor outcomes after lumbar spinal surgery \[[@bib9]\]. DM patients undergoing degenerative cervical spine surgery also have an increased risk for several preoperative complications \[[@bib10]\]. Foot problems remain very common in people with diabetes throughout the world, affecting up to 15% of diabetic patients during their lifetime \[[@bib11]\].

Foot complications, especially foot ulcers, constitute a major public health problem for diabetes patients in sub-Saharan Africa and are important causes of prolonged hospital admission and death in patients from this part of the continent \[[@bib12]\]. Diabetes foot infection due to gangrene is the most common cause of prolonged hospitalization and amputation of their limbs. Besides, 28%--51% of amputated diabetics will have a second amputation of the lower limb within five years of the first amputation \[[@bib13],[@bib14]\].

Generally, diabetic foot complications remain the major medical, social, and economic problems for all types of diabetes \[[@bib11],[@bib15]\]. In Ethiopia, patient habits of poor foot-care practice, and the absence of good quality service of DFU may leads to foot infections which results in limb amputation \[[@bib16]\]. Only a few pharmacists were assigned to avoid the inappropriate use of antibiotics in Nekemte referral hospital (NRH) by intervening problems at only dispensing levels. Despite these challenges, no study has been conducted on risk factor and outcomes of DFU in NRH. This study tried to identify the risk factors and outcomes of DFU patients admitted to NRH.

2. Patients and methods {#sec2}
=======================

2.1. Study setting, design and study period {#sec2.1}
-------------------------------------------

A prospective observational study was conducted at NRH from March 15 to June 15, 2018. The hospital is located in Nekemte town, located 330 km to the west of Addis Ababa, the capital city of Ethiopia. The hospital gives health service for more than 10, 000,000 people living in western Ethiopia. This hospital serves as a referral hospital, a teaching hospital, and research center, and the hospital has one diabetic clinic. There were about 2420 diabetic patients who have been following the diabetic clinic annually. The study population and methods shares similarity with a previously published article by Bekele F et al. \[[@bib17]\]. The work has been reported in line with the strengthening the reporting of cohort studies in surgery (STROCSS) criteria \[[@bib18]\].

2.2. Study participants and eligibility criteria {#sec2.2}
------------------------------------------------

Patients ≥18 years who were diagnosed as diabetes, had DFU, willing to participate in the study and had any visible foot lesions were included. Patients who had traumatic ulcers due to other than normal causes like car accident, burn and any injury due to sharpened materials and who was in acute stress were excluded.

2.3. Study variables and outcome endpoints {#sec2.3}
------------------------------------------

Amputation was the primary outcome and the Wagner classification of DFU was used to assess the severity of foot ulcer. Extent (size) was determined by multiplying the largest by the second largest diameter perpendicular to the first. The etiologies of diabetic foot infection were identified by gram stains. Amputation and healing status was measured using a checklist and assessed by close follow up through telephone interview of the patient/caregiver/proxy on a weekly basis.

2.4. Sample size and sampling technique {#sec2.4}
---------------------------------------

Single population proportion formula was used to calculate the required sample size by considering the following assumptions: n is required sample size, P is incidence of amputation which was 29%, the rate found at Muhimbili National Hospital, Tanzania \[[@bib12]\], Z is standardized normal distribution value at the 95% CI: 1.96 and d is the margin of error of 5%.$$\text{n} = \frac{\left( \text{Z}_{\frac{\alpha}{2}} \right)^{2}\text{p}\left( {1 - \text{p}} \right)}{\text{d}^{2}}$$$$\text{n} = \frac{\left( 1.96 \right)^{2}\mspace{9mu}\left( 0.29 \right)\mspace{9mu}\left( 0.71 \right) = 316}{\left( 0.05 \right)^{2}}$$

The expected number of population in the study period based on the average number of patients visiting the hospital was 156. The corrected sample size, using the correction formula was 104. A 10% contingency yielded a final sample size of 115. Conveniently all patients during the study period fulfilling the eligibility criteria were included in the final analysis.

2.5. Data collection process and management {#sec2.5}
-------------------------------------------

Data was collected using a questionnaire developed after reviewing different literatures and adopting it based on available data. One medical doctor, one nurse and one pharmacist were recruited as data collector and the data was supervised by another medical doctor. A pus swab was obtained from the ulcers before any ulcer cleaning and antibiotics given or debridement done to avoid contamination. The samples were delivered to the laboratory immediately and a thin smear was prepared on grease or oil-free slides. Appropriateness of antibiotics was identified based on standard guidelines of Infectious Diseases Society of America (IDSA) for diagnosis and treatment of diabetic foot infection \[[@bib20]\], which is based on the most likely coverage of antibiotics for treatments of diabetic foot infection for identified gram stain and appropriateness of dosage regimens. Five percent of the sample was pre-tested to check the acceptability and consistency of data collection tool two weeks before the actual data collection. The patients were followed for consecutive three months with telephone interviews after patients were discharged from the hospital.

2.6. Data processing and analysis {#sec2.6}
---------------------------------

The collected data was entered into EPI-manager 4.0.2 and analysis was done using statistical package for social sciences (SPSS) 24. Descriptive data was explained by frequency and percentage. The obtained results were explained by means and standard deviations. Logistic regression was used to analyse the variables and each variable was evaluated independently in bivariate analysis and association was determined using cross-tabulation and crudes odds ratio (COR) with 95% confidence interval (CI). All variables associated with the amputation at a probability level of less than or equal to 0.25 on the bivariate analysis were entered into a multivariate logistic regression analysis to control for confounders. The strength of association was described using adjusted odds ratio (AOR) and variables with a p-value \< 0.05 had a statistically significant association with the amputation.

2.7. Ethics approval and consent to participate {#sec2.7}
-----------------------------------------------

Ethical clearance was obtained from the Institutional Review Board (IRB) of Jimma University, Institute of health with a reference number of [IHRPGC/104/208]{.ul}. The ethics waiver was not applicable since the study was not a randomized clinical trial so that the study subjects were not divided into experimental and control groups. Permission was obtained from the medical director of the NRH to access diabetes patients and conducts the study. The benefit and risks of the study was explained and written consent was obtained from each patient involved in the study. To ensure confidentiality, name and other identifiers of patients and health care professionals were not recorded on the data collection tools. The study was registered [researchregistry.com](http://researchregistry.com){#intref0010} with a unique reference number of "researchregistry5237".

2.8. Operational definitions {#sec2.8}
----------------------------

### 2.8.1. Diabetic Foot ulcer {#sec2.8.1}

The foot of a diabetic patient that has the potential risk of pathologic consequences, including infection, ulceration, and/or destruction of deep tissues.

### 2.8.2. Healing {#sec2.8.2}

The complete closure of the ulcer with skin intact (complete epithelialization) and without drainage or sinus formation.

### 2.8.3. Amputation {#sec2.8.3}

The complete or partial removal of a limb or body appendage by surgical or traumatic means.

### 2.8.4. Minor amputation {#sec2.8.4}

Amputation involving below ankle.

### 2.8.5. Major amputation {#sec2.8.5}

Amputation of legs which involves above the ankle.

### 2.8.6. Grades of diabetic\'s foot ulcer {#sec2.8.6}

For purpose of this study we used Wagner system for classification of diabetic foot ulcer which uses 6 wound grades (scored 0 to 5) to assess ulcer depth \[[@bib19]\].•Grade 0 diabetic foot ulcer: No ulcer, but the foot is at risk for ulceration•Grade 1 diabetic foot ulcer: Superficial ulceration•Grade 2 diabetic foot ulcer: Ulcer with deep infection, but without involvement of the bone•Grade 3 diabetic foot ulcer: Ulcer with osteomyelitis.•Grade 4 diabetic foot ulcer: Presence of localized gangrene on the foot.•Grade 5 diabetic foot ulcer: Presence of gangrene of the whole foot.

### 2.8.7. Neuropathy {#sec2.8.7}

It was diagnosed if the patient had at least one manifestation from the following list of manifestations: burning pain, vibration from the skin, gradual numbness, freezing, extremely sensitive to touch, muscle weakness, and lack of coordination.

### 2.8.8. Peripheral vascular disease {#sec2.8.8}

It is an arterial and vein disease at the peripheral region, which often occurs in diabetic patients.

### 2.8.9. Glycemic control {#sec2.8.9}

Categorized based on American Diabetic Association (ADA) recommendation in to two groups:•**Good glycemic control:** Fasting blood glucose of 70--130 mg/dl.•**Poor glycemic control:** Fasting blood glucose of \<70 mg/dl and \>130 mg/dl

### 2.8.10. Appropriate drug {#sec2.8.10}

Antibiotics prescribed in accordance with infectious diseases society of America (IDSA) guideline for the treatment of diabetic foot infection recommendation based on gram stains and dosage regimens.

### 2.8.11. Inappropriate drug {#sec2.8.11}

Antibiotics prescribed inconsistent with infectious diseases society of America (IDSA) guideline for the treatment of diabetic foot infection recommendation based on gram stains and dosage regimens.

3. Results {#sec3}
==========

3.1. Socio-demographic characteristics {#sec3.1}
--------------------------------------

Over the study period, 115 DFU patients were admitted to the NRH and 64(55.65%) were males. About 26(22.61%) of them were in the age range of 58--67 and the mean age of participants was 44.4 ± 14.7 years. About 34(29.57%) of the DFU patients were overweight and 16(13.91%) were obese while the mean body mass index (BMI) was 24.94 ± 3.69 kg/m^2^([Table 1](#tbl1){ref-type="table"}).Table 1Socio-demographic characteristics of respondents in Nekemte referral hospital, west Ethiopia, 2018.Table 1VariablesFrequency (n)Percent (%)SexMale6455.65Female5144.35Age (years)18--271613.9128--371412.1738--471513.0448--572420.8758--672622.6168--772017.39Marital StatusMarried8069.57Single2118.26Window86.96Divorced65.22ResidenceUrban5850.43Rural5749.57Educational levelIlliterate2420.87Primary school2925.22Secondary school2219.13Above Secondary school4034.78BMI (kg/m^2^)\<24.56556.5224.5--29.53429.57\>29.51613.91[^1]

3.2. Medical conditions and behavioural characteristics {#sec3.2}
-------------------------------------------------------

A total of 58(50.43%) of the participants had foot ulcer and chronic health problems or co-morbidity with other diseases. Among these, 56(48.69%) participants had hypertension as comorbidity. Thirty (26.09%) of the study participants were current smokers and 38 (33.04%) were current alcohol drinkers ([Table 2](#tbl2){ref-type="table"}).Table 2Co-morbidities, complications and behavioural characteristics among diabetic foot ulcer patients attending the Nekemte referral hospital, west Ethiopia, 2018.Table 2VariablesFrequency (n)Percent (%)Co-morbidities and complicationsRetinopathy5547.83Neuropathy5245.22Nephropathy4640.00Hypertension5648.69Peripheral vascular disease4236.52Coronary heart disease/ischemic heart disease4135.65Dyslipidaemia4034.78Behavioural characteristicsPrevious alcohol drinker3933.91Current alcohol drinker3833.04Previous smoker3026.09Current smoker3026.09

Among 115 study participants, 61 (53.04%) of them had type 2 diabetes mellitus. The mean fasting blood glucose level among diabetic patients with foot ulcer was 147.93 ± 45.03 mg/dl. Twenty-six participants (22.61%) were diabetic for more than 10 years and 53(46.09%) participants had poorly controlled blood glucose levels. Among Forty-two (54.55%) patients the isolated micro-organism was gram-positive and ulcer size greater than 5 cm^2^ was identified among 23(20.00%) patients ([Table 3](#tbl3){ref-type="table"}).Table 3Clinical characteristics of diabetic foot ulcer patients among diabetes mellitus patients admitted to Nekemte Referral Hospital, west Ethiopia, 2018.Table 3VariablesFrequency (n)Percent (%)Types of DMType 2 DM6153.04Type 1 DM5446.96Duration of DM\<5years4236.525--10years4740.87\>10 years2622.61Glycaemic controlGood control6253.91Poor control5346.09Size of Ulcer\<1 cm^2^6657.391--5 cm^2^2622.61\>5 cm^2^2320.00

About 9(7.83%) of the patients, dorsal/inter-digital toes were amputated and 4(3.48%) patients had amputation on heel ([Table 4](#tbl4){ref-type="table"}).Table 4The location of diabetic foot ulcer patients admitted to Nekemte referral hospital, west Ethiopia, 2018.Table 4Location of ulcerAmputationYes (%)No (%)Total (%)Dorsal/inter digital toes9(7.83)22(19.13)31(26.96)Plantar forefoot/mid foot/Plantar hind foot11(9.57)26(22.60)37(32.17)Plantar toes6(5.22)24(20.87)30(26.09)Dorsal foot5(4.35)4(3.48)9(7.83)Heel4(3.48)4(3.48)8(6.96)

3.3. Antibiotics prescribed to treat DFU {#sec3.3}
----------------------------------------

Empiric antibiotic regimens were prescribed for DFU patients after gram stain results were obtained and given based on the severity of the infection as well as the likely etiologic agent. Accordingly, an initial antibiotic course for a soft tissue infection of about 7 days for mild infections and 10--21 days for moderate to severe infections were given. Cloxacillin (34.15%) was the most commonly prescribed antibiotic for the treatment of DFU followed by metronidazole and ceftriaxone ([Table 5](#tbl5){ref-type="table"}). From the total patients' given antibiotics, 38(49.35%) of them prescribed appropriately and 39(50.65%) were prescribed inappropriately.Table 5Commonly prescribed individual antibiotics for treating diabetic foot ulcer in Nekemte referral hospital, west Ethiopia, 2018.Table 5AntibioticsFrequency (n)Percent (%)Cloxacillin5634.15Metronidazole4326.22Ceftriaxone3320.12Ampicillin95.49Chrompenicol84.88Gentamycin53.05Ceftazidime42.44Ciprofloxacillin31.83Vancomycin21.22Amoxacillin10.61Total164100

3.4. Risk factors and outcomes of diabetic foot ulcer {#sec3.4}
-----------------------------------------------------

From the patients who developed DFU, 80(69.57%) were healed and 35(30.43%) of them were amputated. From those amputated DFU patients, 20(57.14%) and 15(42.86%) were undergone minor and major amputation, respectively. From the patients who undergone major amputation, 9(60%) of them were amputated below the knee and 6(40%) of them were amputated above the knee. Foot ulcer grade ≥4, inappropriate antibiotics use, overweight, obesity, poor blood glucose control, and neuropathy were found to be predictors of amputation up on multivariable logistic regression analysis.

Those diabetic patients who had Grade ≥4 diabetic foot ulcer were1.7 times more likely to be amputated than those Grade \< 4 diabetic foot ulcer (AOR = 1.7; 95% CI: 1.604, 4.789). Patients with diabetic foot ulcer who had taken inappropriate antibiotics were 2.5 times more likely to be amputated than those who taken appropriate antibiotics (AOR = 2.526; 95% CI: 1.767, 8.314). Overweight diabetic patients were 2.8 times more likely to undergone amputations compared to diabetic patients with normal weight (AOR = 2.767; 95% CI: 1.827, 9.252) and obese diabetic patients were 3 times more likely to undergone amputation as compared to diabetic patients with normal body mass index (AOR = 3.02; 95% CI: 2.556, 16.397). Additionally, those with diabetic foot ulcer who had poor blood glucose control were 2.6 more likely to undergone amputation as compared to diabetic foot ulcer patients who had good controlled blood glucose level (AOR = 2.592; 95% CI: 1.937, 7.168). Furthermore, those DFU patients who had neuropathy were 1.6 times more likely to undergone amputation as compared to those diabetic foot ulcer patients without neuropathy (AOR = 1.565; 95% CI: 1.508, 4.822) ([Table 6](#tbl6){ref-type="table"}).Table 6Multivariate logistic regression analysis result of factors associated with amputation among diabetic foot ulcer patients admitted to NRH, west Ethiopia, 2018.Table 6VariablesAmputationCOR(95%CI)P valueAOR(95%CI)P valueAmputated\
n (%)Not Amputated\
n (%)ResidenceRural17(29.82)40(70.18)1.720\[0.392,7.554\]0.247\*1.547\[0.364,6.579\]0.416Urban18(31.03)40(68.97)11SexMale19(29.69)45(70.31)1.639\[0.169,2.410\]0.158\*1.660\[0.178,2.451\]0.221Female16(31.37)35(68.63)11Drinking Alcohol CurrentlyYes12(31.58)26(68.42)1.516\[0.107,2.485\]0.240\*1.594\[0.128,2.761\]0.693No23(29.87)54(70.13)11Smoking cigarette currentlyYes12(40)18(60)1.426\[0.362,5.622\]0.188\*1.359\[0.346,5.345\]0.222No23(27.06)62(72.94)11Previous history of UlcerYes16(32.65)33(67.35)1.656\[0.175,2.462\]0.235\*1.674\[0.182,2.499\]0.317No19(28.79)47(71.21)11Types of DMType 2 DM23(37.70)38(62.30)1.483\[0.117,2.001\]0.074\*1.431\[0.108,1.715\]0.057Type 1 DM12(22.22)42(77.78)11HypertensionYes16(28.57)40(71.43)2.951\[0.216,4.186\]0.167\*1.109\[0.267,4.604\]0.509No19(32.20)40(67.80)11Ischemic Heart DiseaseYes14(34.15)27(65.85)1.184\[0.298,4.708\]0.152\*1.133\[0.345,5.156\]0.361No21(28.38)53(71.62)11DyslipidaemiaYes13(32.50)27(67.50)2.645\[0.141,2.937\]0.157\*1.766\[0.185,3.170\]0.629No22(29.33)53(70.67)11RetinopathyYes17(30.90)38(69.10)1.345\[0.092,1.386\]0.113\*1.358\[0.097,1.319\]0.052No18(30)42(70)11NeuropathyYes20(38.46)32(61.54)2.658\[1.561,12.602\]0.029\*1.565\[1.508,4.822\]0.004\*\*No15(23.81)48(76.19)11Coronary Heart DiseaseYes9(33.33)18(66.67)1.176\[0.035,2.891\]0.078\*1.179\[0.135,1.915\]0.179No26(29.55)62(70.45)11NephropathyYes18(39.13)28(60.87)1.645\[0.148,2.814\]0.100\*1.227\[0.173,3.013\]0.604No17(24.64)52(75.36)11Peripheral Vascular DiseaseYes13(30.95)29(69.05)1.243\[0.283,5.452\]0.177\*1.440\[0.343,6.048\]0.864No22(30.14)51(69.86)11Body mass index\<24.515(23.08)50(76.92)10.073\*10.12224.5--29.512(35.29)22(64.71)7.054\[1.410,35.296\]0.032\*2.767\[1.827,9.252\]0.021\*\*\>29.58(50)8(50)7.729\[2.828,72.134\]0.017\*3.020\[2.556,16.397\]0.019\*\*Glycaemic ControlPoor Control21(39.62)32(60.38)2.779\[1.755,10.231\]0.048\*2.592\[1.937,7.168\]0.023\*\*Good Control14(22.58)48(77.42)11Duration of Diabetic Mellitus\<5years14(33.33)28(66.67)10.184\*10.1745--10years14(29.79)33(70.21)2.273\[0.299,5.418\]0.071\*1.171\[0.279,4.910\]0.061\>10years7(26.92)19(73.08)1.672\[0.112,4.011\]0.157\*1.596\[0.103,3.439\]0.558Size of Ulcer\<1 cm^2^16(24.24)50(75.76)10.215\*10.1091--5 cm^2^11(42.31)15(57.69)1.515\[0.109,2.431\]0.190\*1.608\[0.139,2.665\]0.253\>5 cm^2^8(34.78)15(65.22)1.881\[0.154,5.027\]0.132\*1.894\[0.158,5.054\]0.130Appropriateness of AntibioticsInappropriate21(53.85)18(46.15)6.192\[1.108,34.614\]0.012\*2.526\[1.767,8.314\]0.017\*\*Appropriate14(36.84)24(63.16)11Grade of UlcerGrade\
\<419(21.84)68(78.16)10.001\*10.005\*\*Grade\
≥416(57.14)12(42.86)3.209 \[1.790,13.033\]1.70\[1.604,4.789\][^2][^3]

4. Discussion {#sec4}
=============

This study tried to assess the risk factors and outcomes of DFU patients admitted NRH, western Ethiopia. This study found that almost half of the patients had poor glycaemic control and revealed that poor blood glucose control patients were more likely to be amputated as compared with those who had good blood glucose control. This was consistent with the studies conducted in USA, Germany, India, and Sudan \[[@bib9],[@bib13],[@bib21],[@bib22]\]. This indicates that the importance of glycaemic control should be implied and emphasized by these findings as a key aspect of primary intervention in DFU management and prevention of unnecessary limb wastage. Therefore, optimal control of plasma glucose will decrease the risk of amputation in diabetic foot ulcer patients.

The result of this study showed that overweight and obese DFU patients were 2.8 and 3 times more likely to undergone amputation as compared to those who had a normal BMI, respectively. This was consistent with the study conducted in Gondar \[[@bib23]\]. But the study done in Kenya showed that BMI was not associated with diabetic foot ulcer \[[@bib6]\]. The possible reason could be due to the decreased blood flow circulations to the lower limb as a result of fat accumulations among higher BMI patients.

Advanced Wagner stage ulcers were a significant risk factor for amputation. DFU patients who had Wagner Grade ≥4 were 1.7 times more likely to be amputated as compared to diabetic foot ulcer patients who had Wagner Grade \<4. This result was consistent with the studies conducted in USA and Tanzania \[[@bib12],[@bib24]\]. The possible reason was most of the patients in advanced Wagner stage were developed gangrene.

Peripheral neuropathy was another variable that predicts of amputation in diabetic foot ulcer patients. Diabetic patients who had neuropathy were 1.6 times more likely to be amputated as compared to diabetic patients without neuropathy. This result was consistent with the studies conducted in Germany and Gondar \[[@bib19],[@bib23]\]. This might due to peripheral neuropathy exposes the patient for the infection of their feet as a result of the increase in the duration of pressure over the diabetic foot. Additionally, higher blood glucose level can result in damage of peripheral nerves which increase the risk of amputation.

The most commonly prescribed individual antibiotics in NRH during the study period was cloxacillin 56(34.15%) followed by metronidazole 43(26.22%) and ceftriaxone 33(20.12%). Study in UK by Wong ML and Coppini DV showed that the most commonly prescribed antibiotics were cefradine, clindamycin, and ciprofloxacin \[[@bib25]\]. However, the study done in Sweden showed that metronidazole (56%) and ciprofloxacin (54%) were the most commonly used, followed by flucloxacillin (40%) and cefadroxil (31%) \[[@bib26]\]. Additionally, the study done in Switzerland by pittet D also showed that the antibiotics most commonly used included semi-synthetic penicillins, second and third-generation cephalosporins and fluoroquinolones \[[@bib27]\]. The variety of individual antibiotic use in a variety of settings was mostly due to the etiologic agent identified, patient condition, availability of the drugs, and preference of the physicians.

The outcome of DFU was strongly associated with inappropriate antibiotics given to treat diabetic foot infection. Diabetes foot ulcers who had taken inappropriate antibiotics were 2.5 more times to be amputated than diabetic foot ulcer which had been treated with appropriate antibiotics. This was correlated with the study conducted in UK in which the amputation rate dropped from about 70% to about 30% with appropriate antibiotic therapy \[[@bib28]\]. In our study area, about half of the antibiotics were prescribed inappropriately. Therefore, because of excessive and inappropriate use of antibiotics for treating diabetic foot infections, treatment failure and the risk of amputation increased. Inappropriate antibiotics prescription results in the risk of development of resistant pathogens.

The duration of diabetes prior to presentation didn\'t affect the outcome of diabetic foot ulcers. Previous studies done in Germany, Pakistan, Jamaica, Khartoum and Arbaminch have demonstrated the inhibitory effects of diabetes on wound healing but the duration of diabetes independently may not be as important as overall blood glucose control (which was not looked at in this study) \[[@bib13],[@bib21],[@bib29], [@bib30], [@bib31]\].

Diabetic patients who lived in rural areas often walk with bare feet. This may expose their feet to be injured and may resulted in infections. Despite this, most of the patients in our study area were come from urban and the place of the residence had no significant associations with the outcomes of DFU. However, previous studies conducted in Pakistan, Arbaminch and Gondar had demonstrated that DFU significantly associated with the rural residence of the patients \[[@bib23],[@bib29]-[@bib30]\].

From the total diabetic foot ulcer patients, 35(30.43%) were amputated and from those amputated 20(57.14%) and 15(42.86%) were undergone minor and major amputations, respectively. This figure was comparable with the study done in Tanzania and Pakistan \[[@bib12],[@bib30]\]. However, lower than the study done in Singapore \[[@bib32]\]. Additionally, the finding was higher than the study done in university of Malta \[[@bib33]\] and Alfayha teaching hospital, Iraq \[[@bib34]\]. This was due to the differences in quality of diabetic foot care and the difficulty of obtaining consent for major or even minor surgery that required amputation of an affected limb. The reason for this reluctance lies in part in cultural factors where the loss of limb may be considered worse than loss of life.

4.1. Strength and limitation of the study {#sec4.1}
-----------------------------------------

As a strength, the study was a prospective observational design that helps as baseline information for other researchers. As limitations, fasting plasma glucose was used to assess the adequacy of glycemic control instead of glycosylated hemoglobin (HbA1c) due to availability problems. Additionally, culture and sensitivity tests were not done to identify specific strains of the pathogens. Further, in our country, there was no guideline on antibiotics management of diabetic foot ulcer. As a result, the appropriateness of antibiotics was identified based on standard guidelines of Infectious Diseases Society of America (IDSA) for diagnosis and treatment of diabetic foot infection. Finally, the follow-up period was short, thus failing to take into account any non-healing ulcers resulting in amputation after three months. After patients were discharged we followed up patients by telephone, not by face to face interview thus the accuracy of these self-reported events needs to be evaluated.

5. Conclusion {#sec5}
=============

Blood glucose level, Higher BMI (overweight and obesity), inappropriate antibiotics given, neuropathy, and advanced grade of diabetic foot ulcer were factors that predicted the amputation among DFU patients. The rate of amputation of the DFU was found to be high in which most of the patients were amputated below the ankle. The most commonly prescribed antibiotics for treating diabetic foot ulcer was cloxacillin and about half of antibiotics were prescribed inappropriately.

To reduce the associated unwelcomed effects of DFU, especial emphasis should be given for patients having neuropathy and advanced grade of diabetic foot ulcer. To minimize the risk of developing DFU, health educators should emphasize the benefit of weight reduction and managing hyperglycaemia. Additionally, laboratory services should be strengthened like culture and sensitivity tests to identify the specific strain of the pathogen for definitive treatment. Through these prescribers should have to minimize empiric antibiotics prescribing to the possible level. Despite the mortality that was not reported in our study, previous studies found as a primary outcome for DFU. Therefore, we recommend further research to identify mortality rates and associated factors.
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[^1]: BMI: Body mass index NGO: Non-governmental organization.

[^2]: Note \*Shows statistically significant p-value ≤0.25 at 95% CI.

[^3]: \*\*Shows statistically significant p-value ≤0.05 at 95% CI.
